Conference Reports for NATAP
EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026
Back
 
Linafexor in UCDA-inadequate PBC: A phase 2 trial of a pulsatile FXR agonist
EASL 2026 Ma6-30 Barcelona